Trial Profile
1st line chemotherapy of XELoda/OXaliplatin for advanced Gastric cancer PI
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Jun 2017
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Oxaliplatin
- Indications Gastric cancer
- Focus Adverse reactions
- Acronyms G-XELOX PI
- 17 Jun 2017 Status changed from active, no longer recruiting to completed.
- 20 Dec 2014 New trial record